Olavide Neuron STX, S.L. capta un millón de eurospara impulsar el desarrollo de ONESTX-1 | Inversores como Axon Desarrollo Andalucía, Anecon Inversiones, Biomedal, Eoniq Fund y Francisco León apues...
Read moreThe funding will be used to advance the clinical development of SpliceBio’s lead gene therapy candidate, SB-007 for Stargardt disease, including the ongoing interventional Phase 1/2 ASTRA study and ...
Read moreThe Aortyx team is developing a minimally invasive solution for aortic dissection, essentially a tear in the aortic wall. To this end, they have created a steerable catheter that is inserted through t...
Read moreAortyx, the medical device company backed by IQS-URL, has raised 13.8 million euros in Series A funding to advance its bioabsorbable aortic patch to the first clinical trials in patients within two ye...
Read moreA team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression o...
Read moreThe financial services company Inveready, a member of Catalonia.health, announces the successful closure of its life sciences fund Inveready Innvierte Biotech II. This is the second fund the firm has ...
Read moreNew U.S. investment bank joins, bringing total coverage to ten analysts
Read moreUn nuevo estudio identifica una vía terapéutica prometedora para restaurar la capacidad de las lipoproteínas HDL de eliminar el colesterol de las células musculares lisas vasculares (VSMCs), impli...
Read moreBetween December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant...
Read moreProceeds to support further clinical development of lead program ATX-01 in Myotonic Dystrophy Type1, a unique therapy currently in Phase I-IIa, targeting miR23b
Read moreThe focus is on how genes are regulated in the brain, a process that plays a key role in the development of autism. As a result, the team has designed a drug that works differently from current treatm...
Read moreIt was known that trees could survive extreme water shortages thanks to their ability to produce more numerous and smaller vessels, but the molecular mechanisms underlying this response were unknown. ...
Read more